Status:
COMPLETED
4D PET/CT in Diagnosing Participants With Lung and Colorectal Cancer With Liver and Lung Metastasis
Lead Sponsor:
M.D. Anderson Cancer Center
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Metastatic Malignant Neoplasm in the Liver
Metastatic Malignant Neoplasm in the Lung
Eligibility:
All Genders
18+ years
Brief Summary
This trial studies how well 4 dimensional (D) positron emission tomography/computed tomography (PET/CT) works in diagnosing participants with lung or colorectal cancer that has spread to the liver and...
Detailed Description
PRIMARY OBJECTIVES: I. Study the impact of 4D positron emission tomography/computed tomography (PET/CT) imaging on the evaluation and staging of lung and colorectal cancer. OUTLINE: Participants un...
Eligibility Criteria
Inclusion
- Patients with suspected colorectal cancer with nodules in the lung or liver (1-2 cm in diameter) will be eligible for this study.
- Patients with suspected lung cancer with nodules in the lung or liver (1-2 cm in diameter) will be eligible for this study.
Exclusion
- Patients that cannot tolerate being scanned for an additional 12 minutes with arms above their head will be excluded.
Key Trial Info
Start Date :
March 12 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 28 2019
Estimated Enrollment :
75 Patients enrolled
Trial Details
Trial ID
NCT00862680
Start Date
March 12 2009
End Date
April 28 2019
Last Update
April 14 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
M D Anderson Cancer Center
Houston, Texas, United States, 77030